Matthew Vasil, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Elaine B Scott, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 Carlisle St, Natrona Heights, PA 15065 Phone: 724-226-7330 Fax: 724-226-7150 |
Jeffrey Lineman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Suite 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Benjamin Carnahan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Dr. Vincent Bolisay Vargas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1719 Union Ave Ste A, Natrona Heights, PA 15065 Phone: 724-226-2128 Fax: 724-226-2498 |
Dr. Kaleigh Spencer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Luke Jesser, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Suite 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Ramey Ka Yan Roppel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
Rachel Wolfe, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1604 Burtner Rd, Ste 2300, Natrona Heights, PA 15065 Phone: 724-226-1400 |
News Archive
The quantities are very small, but in milk powder and in meat-based baby food, residues of drugs given to livestock were found. Researchers from the University of Almeria have developed a system to analyse these substances quickly and precisely.
Entest BioMedical Inc. (OTC Bulletin Board: ENTB) announced today the filing of a third patent application relating to the area of chronic obstructive pulmonary disease (COPD), a condition that affects more than 5 million patients in the United States, resulting in more than 120,000 deaths per year. The application covers an implantable medical device useful in re-directing the immune system to stop tissue inflammation.
PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company TTY Biopharm to market and distribute the drug candidate APLIDIN (plitidepsin) in Taiwan. Under the terms of the agreement, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by APLIDIN (plitidepsin).
Triple-S Management Corporation, the largest managed care company in Puerto Rico, today announced consolidated operating revenues of $519.1 million and operating income of $16.4 million for the three months ended March 31, 2010. Net income of $11.2 million, or $0.38 per diluted share, includes an after tax net gain of $0.4 million, or $0.01 per share, in net realized and unrealized gains on investments and derivatives.
› Verified 5 days ago